Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae case

References

• Aldeyab M, López-Lozano JM, Gould IM. Global antibiotics use and resistance. In: Babar ZUD, editor. Global pharmaceutical policy. Singapore: Palgrave Macmillan; 2020. p. 331–344. doi: 10.1007/978-981-15-2724-1_13
   Google Scholar
• O’Neill J Antimicrobial Resistance: tackling a crisis for the health and wealth of nations. The Review on Antimicrobial Resistance. 2014. (cited 6 Aug 2022). Available online: https://amr-review.org/Publications.html
   Google Scholar
• Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. doi: 10.1016/S0140-6736(21)02724-0
   PubMed Web of Science ®Google Scholar
• Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004;10(S12):S122–S129. doi: 10.1038/nm1145
   PubMedGoogle Scholar
• Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–433. doi: 10.1128/MMBR.00016-10
   PubMed Web of Science ®Google Scholar
• Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis. 2002;8(4):347–354. doi: 10.3201/eid0804.010312
   PubMed Web of Science ®Google Scholar
• Tomson G, Vlad I. The need to look at antibiotic resistance from a health systems perspective. Ups J Med Sci. 2014;119(2):117–124. doi: 10.3109/03009734.2014.902879
   PubMed Web of Science ®Google Scholar
• Martin RM, Bachman MA. Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae. Front Cell Infect Microbiol query. 2018;8:4. doi: 10.3389/fcimb.2018.00004
   PubMed Web of Science ®Google Scholar
• Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care–associated infections. N Engl J Med. 2014;370(13):1198–1208. doi: 10.1056/NEJMoa1306801
   PubMed Web of Science ®Google Scholar
• Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11(4):589–603. doi: 10.1128/CMR.11.4.589
   PubMed Web of Science ®Google Scholar
• Gupta A, Ampofo K, Rubenstein D, et al. Extended spectrum β lactamase-producing klebsiella pneumoniae infections: a review of the literature. J Perinatol. 2003;23(6):439–443. doi: 10.1038/sj.jp.7210973
   PubMedGoogle Scholar
• Becker L, Fuchs S, Pfeifer Y, et al. Whole genome sequence analysis of CTX-M-15 producing Klebsiella isolates allowed dissecting a polyclonal outbreak scenario. Front Microbiol. 2018;9:322. doi: 10.3389/fmicb.2018.00322
   PubMed Web of Science ®Google Scholar
• Paterson DL, Bonoma RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657–686. doi: 10.1128/CMR.18.4.657-686.2005
   PubMed Web of Science ®Google Scholar
• Ramphal R, Ambrose PG. Extended-Spectrum β-Lactamases and clinical outcomes: current data. Clin Infect Dis. 2006;42(Supplement_4):164–187. doi: 10.1086/500663
   Google Scholar
• Rodríguez-Baño J, Picón E, Gijón P, et al. Community-onset bacteremia due to extended-spectrum β-lactamase–producing escherichia coli: risk factors and prognosis. Clin Infect Dis. 2010;50(1):40–48. doi: 10.1086/649537
   PubMed Web of Science ®Google Scholar
• Kritsotakis EI, Tsioutis C, Roumbelaki M, et al. Antibiotic use and the risk of carbapenem-resistant extended-spectrum- -lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J Antimicrob Chemother. 2011;66(6):1383–1392. doi: 10.1093/jac/dkr116
   PubMed Web of Science ®Google Scholar
• Jirjees FJ, Al-Obaidi HJ, Sartaj M, et al. Antibiotic use and resistance in hospitals: time-series analysis strategy for determining and prioritising interventions. Hosp Pharm Eur. 2020;95:13–19. Available online: https://hospitalpharmacyeurope.com/news/reviews-research/antibiotic-use-and-resistance-in-hospitals-time-series-analysis-strategy-for-determining-and-prioritising-interventions/
   Google Scholar
• Monnet DL, López-Lozano JM, Campillos P, et al. Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models. Clin Microbiol Infect. 2001;7(Suppl 5):29–36. doi: 10.1046/j.1469-0691.2001.00071.x
   PubMedGoogle Scholar
• López-Lozano JM, Monnet DL, Yagüe A, et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents. 2000;14(1):21–31. doi: 10.1016/S0924-8579(99)00135-1
   PubMed Web of Science ®Google Scholar
• Monnet DL, MacKenzie FM, López-Lozano JM, et al. Antimicrobial drug use and methicillin-resistant staphylococcus aureus , aberdeen, 1996–2000. Emerg Infect Dis. 2004;10(8):1432–1441. doi: 10.3201/eid1008.020694
   PubMed Web of Science ®Google Scholar
• Aldeyab MA, Monnet DL, López-Lozano JM, et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother. 2008;62(3):593–600. doi: 10.1093/jac/dkn198
   PubMed Web of Science ®Google Scholar
• Lopez-Lozano JM, Lawes T, Nebot C, et al. A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance. Nat Microbiol. 2019;4(7):1160–1172. doi: 10.1038/s41564-019-0410-0
   PubMed Web of Science ®Google Scholar
• Lawes T, Lopez-Lozano JM, Nebot CA, et al. Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study. Lancet Infect Dis. 2015;15(12):1438–1449. doi: 10.1016/S1473-3099(15)00315-1
   PubMed Web of Science ®Google Scholar
• Lawes T, Lopez-Lozano JM, Nebot C, et al. Turning the tide or riding the waves? Impacts of antibiotic stewardship and infection control on MRSA strain dynamics in a Scottish region over 16 years: non-linear time series analysis. BMJ Open. 2015;5(3):e006596. doi: 10.1136/bmjopen-2014-006596
   PubMed Web of Science ®Google Scholar
• Hayajneh WA, Al-Azzam S, Yusef D, et al. Identification of thresholds in relationships between specific antibiotic use and carbapenem-resistant Acinetobacter baumannii (CRAb) incidence rates in hospitalized patients in Jordan. J Antimicrob Chemother. 2021;76(2):524–530. doi: 10.1093/jac/dkaa463
   PubMed Web of Science ®Google Scholar
• Al-Hashimy ZS, Conway BR, Al-Yaqoobi M, et al. Identifying Targets for antibiotic use for the management of carbapenem-resistant acinetobacter baumannii (CRAb) in hospitals-a multi-centre nonlinear time-series study. Antibiotics (Basel). 2022;11(6):775. doi: 10.3390/antibiotics11060775
   PubMed Web of Science ®Google Scholar
• Colodner R, Rock W, Chazan B, et al. Risk factors for the development of extended spectrum beta lactamase producing bacteria in non-hospitalised patients. Eur J Clin Microbiol Infect Dis. 2004;23(3):163–167. doi: 10.1007/s10096-003-1084-2
   PubMed Web of Science ®Google Scholar
• Graffunder EM, Preston KE, Evans AM, et al. Risk factors associated with extended-spectrum β-lactamase-producing organisms at a tertiary care hospital. J Antimicrob Chemother. 2005;56(1):139–145. doi: 10.1093/jac/dki180
   PubMed Web of Science ®Google Scholar
• Vibet MA, Roux J, Montassier C, et al. Systematic analysis of the relationship between antibiotic use and extended spectrum beta-lactamase resistance in enterobacteriaceae in a French Hospital: a time series analysis. Eur J Clin Microbiol Infect Dis. 2015;34(10):1957–1963. doi: 10.1007/s10096-015-2437-3
   PubMed Web of Science ®Google Scholar
• Kaier K, Frank U, Hagist C, et al. The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum -lactamase-producing strains: a time-series analysis. J Antimicrob Chemother. 2009;63(3):609–614. doi: 10.1093/jac/dkn534
   PubMed Web of Science ®Google Scholar
• Vernaz N, Huttner B, Muscionico D, et al. Modelling the impact of antibiotic use on antibiotic resistant Escherichia coli using population based data from a large hospital and surrounding community. J Antimicrob Chemother. 2011;66(4):928–935. doi: 10.1093/jac/dkq525
   PubMed Web of Science ®Google Scholar
• Aldeyab MA, Harbarth S, Vernaz N, et al. The impact of antibiotic use on the incidence and resistance pattern of extended spectrum beta-lactamase producing bacteria in primary and secondary healthcare settings. Br J Clin Pharmacol. 2012;74(1):171–179. doi: 10.1111/j.1365-2125.2011.04161.x
   PubMed Web of Science ®Google Scholar
• Coia JE, Duckworth GJ, Edwards DI, et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect. 2006;63 Suppl 1:S1–44. Erratum in: J Hosp Infect. 2006; 64(1):97-8. doi: 10.1016/j.jhin.2006.01.001
   PubMed Web of Science ®Google Scholar
• Ventola CL. The antibiotic resistance crisis: part 2: management strategies and new agents. P T. 2015;40(5):344–352.
   PubMedGoogle Scholar
• Lushniak BD. Antibiotic resistance: a public health crisis. Public Health Rep. 2014;129(4):314–316. doi: 10.1177/003335491412900402
   PubMed Web of Science ®Google Scholar
• Mathur P. Hand hygiene: back to the basics of infection control. Indian J Med Res. 2011;134(5):611–620. doi: 10.4103/0971-5916.90985
   PubMedGoogle Scholar
• Allegranzi B, Pittet D. Role of hand hygiene in healthcare-associated infection prevention. J Hosp Infect. 2009;73(4):305–315. doi: 10.1016/j.jhin.2009.04.019
   PubMed Web of Science ®Google Scholar
• Lotfinejad N, Peters A, Tartari E, et al. Hand hygiene in health care: 20 years of ongoing advances and perspectives. Lancet Infect Dis. 2021;21(8):e209–e221. doi: 10.1016/S1473-3099(21)00383-2
   PubMed Web of Science ®Google Scholar
• Barrera L, Zingg W, Mendez F, et al. Effectiveness of a hand hygiene promotion strategy using alcohol-based handrub in 6 intensive care units in Colombia. Am J Infect Control. 2011;39(8):633–639. doi: 10.1016/j.ajic.2010.11.004
   PubMed Web of Science ®Google Scholar
• Kingston L, O’Connell NH, Dunne CP. Hand hygiene-related clinical trials reported since 2010: a systematic review. J Hosp Infect. 2016;92(4):309–320. doi: 10.1016/j.jhin.2015.11.012
   PubMed Web of Science ®Google Scholar
• Levy SB. Balancing the drug-resistance equation. Trends Microbiol. 1994;2(10):341–342. doi: 10.1016/0966-842X(94)90607-6
   PubMedGoogle Scholar
• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi: 10.1016/S1473-3099(17)30753-3
   PubMed Web of Science ®Google Scholar
• Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 2016;80(3):629–661. doi: 10.1128/MMBR.00078-15
   PubMed Web of Science ®Google Scholar
• Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9(4):228–236. doi: 10.1016/S1473-3099(09)70054-4
   PubMed Web of Science ®Google Scholar
• Wiener J, Quinn JP, Bradford PA, et al. Multiple antibiotic–resistant klebsiella and escherichia coli in nursing homes. JAMA. 1999;281(6):517–523. doi: 10.1001/jama.281.6.517
   PubMed Web of Science ®Google Scholar
• Lee SO, Lee ES, Park SY, et al. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2004;25(10):832–837. doi: 10.1086/502304
   PubMed Web of Science ®Google Scholar
• Lautenbach E, Patel JB, Bilker WB, et al. Extended-spectrum -lactamase-producing escherichia coli and klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32(8):1162–1171. doi: 10.1086/319757
   PubMed Web of Science ®Google Scholar
• Nham E, Huh K, Cho SY, et al. Characteristics and clinical outcomes of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in cancer patients. Infect Chemother. 2020;52(1):59–69. doi: 10.3947/ic.2020.52.1.59
   PubMed Web of Science ®Google Scholar
• Magiorakos A-P, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi: 10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing—Twenty-Sixth Edition: m100. Wayne PA USA: CLSI; 2016.
   Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment, 2023. Oslo, 2022. cited 1 Apr 2023. https://www.whocc.no/atc_ddd_index_and_guidelines/guidelines/
   Google Scholar
• Friedman J. Multivariate adaptive regression splines. Ann Statist. 1991;19(1):1–67. doi: 10.1214/aos/1176347963.
   Web of Science ®Google Scholar
• Hastie T, Tibshirani R. Generalized additive models. London: Chapman & Hall; 1990.
   Google Scholar
• Liu L-M. Time Series Analysis and Forecasting. 2nd edn ed. River Forest IL USA: Scientific Computing Associates Corp; 2009.
   Google Scholar
• Hecker MT, Aron DC, Patel NP, et al. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med. 2003;163(8):972–978. doi: 10.1001/archinte.163.8.972
   PubMedGoogle Scholar
• Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017;2(2): CD003543. doi: 10.1002/14651858.CD003543.pub4
   PubMedGoogle Scholar
• Haber M, Levin BR, Kramarz P. Antibiotic control of antibiotic resistance in hospitals: a simulation study. BMC Infect Dis. 2010;10(1):254. doi: 10.1186/1471-2334-10-254
   PubMedGoogle Scholar
• Aldeyab MA, Harbarth S, Vernaz N, et al. Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients. Antimicrob Agents Chemother. 2009;53(5):2082–2088. doi: 10.1128/AAC.01214-08
   PubMed Web of Science ®Google Scholar
• Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098. doi: 10.1016/S1473-3099(13)70318-9
   PubMed Web of Science ®Google Scholar
• Dellit TH, Owens RC, McGowan JE, et al. Infectious diseases society of america and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–177. doi: 10.1086/510393
   PubMed Web of Science ®Google Scholar
• Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003;24(5):362–386. doi: 10.1086/502213
   PubMed Web of Science ®Google Scholar
• Lemmen SW, Lewalter K. Antibiotic stewardship and horizontal infection control are more effective than screening, isolation and eradication. Infection. 2018;46(5):581–590. doi: 10.1007/s15010-018-1137-1
   PubMed Web of Science ®Google Scholar
• Wilson J. Infection control in clinical practice. 3rd ed. London: Bailliere Tindall; 2006.
   Google Scholar
• Ya K Z, Win PTN, Bielicki J, et al. Association between antimicrobial stewardship programs and antibiotic use globally: a systematic review and meta-analysis. JAMA Netw Open. 2023;6(2):e2253806. doi: 10.1001/jamanetworkopen.2022.53806
   PubMedGoogle Scholar
• Goto M, O’Shea AMJ, Livorsi DJ, et al. The effect of a nationwide infection control program expansion on hospital-onset gram-negative rod bacteremia in 130 veterans health administration medical centers: an interrupted time-series analysis. Clin Infect Dis. 2016;63(5):642–650. doi: 10.1093/cid/ciw423
   PubMed Web of Science ®Google Scholar
• Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme Lancet. 2000;356(9238):1307–1312. doi: 10.1016/S0140-6736(00)02814-2
   PubMed Web of Science ®Google Scholar
• Gordin FM, Schultz ME, Huber RA, et al. Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infect Control Hosp Epidemiol. 2005;26(7):650–653. doi: 10.1086/502596
   PubMed Web of Science ®Google Scholar
• Pittet D, Allegranzi B, Sax H, et al. Evidence-based model for hand transmission during patient care and the role of improved practices. Lancet Infect Dis. 2006;6(10):641–652. doi: 10.1016/S1473-3099(06)70600-4
   PubMed Web of Science ®Google Scholar
• Aldeyab MA, McElnay JC, Scott MG, et al. Hospital antibiotic use and its relationship to age-adjusted comorbidity and alcohol-based hand rub consumption. Epidemiol Infect. 2014;142(2):404–408. doi: 10.1017/S0950268813001052
   PubMed Web of Science ®Google Scholar
• Aldeyab MA, McElnay JC, Scott MG, et al. A modified method for measuring antibiotic use in healthcare settings: implications for antibiotic stew-ardship and benchmarking. J Antimicrob Chemother. 2014;69(4):1132–1141. doi: 10.1093/jac/dkt458
   PubMed Web of Science ®Google Scholar
• Conlon-Bingham GM, Aldeyab M, Scott M, et al. Effects of antibiotic cycling policy on incidence of healthcare-associated MRSA and clostridioides difficile infection in secondary healthcare settings. Emerg Infect Dis. 2019;25(1):52–62. doi: 10.3201/eid2501.180111
   PubMed Web of Science ®Google Scholar